| Literature DB >> 29411507 |
Claire M Nightingale1, Alicja R Rudnicka1, Sarah R Kerry-Barnard1, Angela S Donin1, Soren Brage2, Kate L Westgate2, Ulf Ekelund2,3, Derek G Cook1, Christopher G Owen1, Peter H Whincup1.
Abstract
BACKGROUND: The relationship between physical fitness and risk markers for type 2 diabetes (T2D) in children and the contribution to ethnic differences in these risk markers have been little studied. We examined associations between physical fitness and early risk markers for T2D and cardiovascular disease in 9- to 10-year-old UK children.Entities:
Keywords: children; ethnicity; physical fitness; type 2 diabetes
Mesh:
Substances:
Year: 2018 PMID: 29411507 PMCID: PMC5969256 DOI: 10.1111/pedi.12637
Source DB: PubMed Journal: Pediatr Diabetes ISSN: 1399-543X Impact factor: 4.866
Estimated VO2 max and risk markers for type 2 diabetes and cardiovascular disease by sex and ethnic group
| Geometric mean/mean | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boys ( | Girls ( | White European ( | South Asian ( | Black African‐Caribbean ( | Other ( |
| |||||||
| Fat mass index (kg/m5) | 2.0 | (1.9, 2.0) | 2.2 | (2.1, 2.3) | 2.1 | (2.0, 2.2) | 2.1 | (2.1, 2.2) | 1.9 | (1.8, 2.0) | 2.2 | (2.1, 2.3) | <.0001 |
| Estimated VO2 max (mL O2/min/kg) | 40.8 | (40.4, 41.2) | 37.9 | (37.5, 38.3) | 39.3 | (38.9, 39.8) | 38.5 | (37.9, 39.0) | 40.3 | (39.8, 40.8) | 39.3 | (38.8, 39.8) | <.0001 |
| Physical activity counts (×1000) | 437 | (428, 445) | 364 | (356, 373) | 400 | (390, 410) | 378 | (367, 390) | 422 | (411, 432) | 398 | (387, 408) | <.0001 |
| Insulin (mU/L) | 6.53 | (6.16, 6.92) | 8.05 | (7.59, 8.53) | 6.26 | (5.84, 6.72) | 8.68 | (8.03, 9.39) | 6.64 | (6.16, 7.16) | 7.69 | (7.14, 8.28) | <.0001 |
| HOMA‐insulin resistance | 0.82 | (0.78, 0.87) | 1.00 | (0.94, 1.06) | 0.78 | (0.73, 0.83) | 1.08 | (1.01, 1.17) | 0.83 | (0.77, 0.90) | 0.96 | (0.89, 1.03) | <.0001 |
| HbA1c (%) | 5.29 | (5.26, 5.31) | 5.29 | (5.26, 5.31) | 5.23 | (5.20, 5.26) | 5.33 | (5.29, 5.37) | 5.30 | (5.27, 5.34) | 5.29 | (5.25, 5.32) | <.001 |
| HbA1c (mmol/mol) | 34.0 | (33.8, 34.3) | 34.1 | (33.8, 34.4) | 33.5 | (33.1, 33.8) | 34.5 | (34.1, 34.9) | 34.2 | (33.8, 34.6) | 34.1 | (33.7, 34.5) | <.001 |
| Glucose (mmol/L) | 4.51 | (4.49, 4.54) | 4.43 | (4.40, 4.45) | 4.45 | (4.41, 4.48) | 4.51 | (4.47, 4.55) | 4.43 | (4.39, 4.46) | 4.49 | (4.46, 4.53) | .002 |
| Urate (mmol/L) | 0.22 | (0.21, 0.22) | 0.23 | (0.22, 0.23) | 0.22 | (0.22, 0.23) | 0.23 | (0.22, 0.23) | 0.21 | (0.20, 0.21) | 0.23 | (0.22, 0.23) | <.0001 |
| C‐reactive protein (mg/L) | 0.45 | (0.41, 0.49) | 0.60 | (0.54, 0.65) | 0.48 | (0.43, 0.55) | 0.58 | (0.51, 0.67) | 0.46 | (0.40, 0.53) | 0.55 | (0.48, 0.63) | .06 |
| Triglyceride (mmol/L) | 0.80 | (0.78, 0.83) | 0.89 | (0.86, 0.92) | 0.83 | (0.80, 0.86) | 0.96 | (0.92, 1.00) | 0.73 | (0.70, 0.76) | 0.87 | (0.84, 0.91) | <.0001 |
| HDL‐cholesterol (mmol/L) | 1.53 | (1.51, 1.56) | 1.46 | (1.44, 1.48) | 1.51 | (1.48, 1.54) | 1.44 | (1.41, 1.48) | 1.55 | (1.51, 1.59) | 1.48 | (1.45, 1.52) | <.001 |
| LDL‐cholesterol (mmol/L) | 2.55 | (2.50, 2.60) | 2.52 | (2.48, 2.57) | 2.52 | (2.45, 2.58) | 2.56 | (2.49, 2.63) | 2.50 | (2.44, 2.58) | 2.56 | (2.49, 2.63) | .56 |
| Systolic blood pressure (mm Hg) | 105.2 | (104.3, 106.2) | 103.6 | (102.7, 104.6) | 105.1 | (103.9, 106.3) | 104.6 | (103.3, 105.9) | 102.5 | (101.2, 103.8) | 105.5 | (104.2, 106.7) | <.001 |
| Diastolic blood pressure (mm Hg) | 62.9 | (62.1, 63.7) | 63.3 | (62.5, 64.1) | 62.6 | (61.6, 63.6) | 63.8 | (62.6, 64.9) | 62.7 | (61.6, 63.7) | 63.4 | (62.4, 64.5) | .32 |
Geometric means are shown for all variables which are log‐transformed.
Means presented by sex are adjusted for age (in quartiles), ethnic group, month of measurement height, and school (random effect).
Means presented by ethnic group are adjusted for sex, age (in quartiles), month of measurement height, and school (random effect).
Means are shown for untransformed variables.
P‐value for heterogeneity in association with ethnic group.
N = 1083 for physical activity counts.
Associations between estimated VO2 max and risk markers for type 2 diabetes and cardiovascular disease with additional adjustment for fat mass index (FMI)
| Risk markers ( | Adjustments | Percentage difference/difference |
| |
|---|---|---|---|---|
| FMI (kg/m5) | Standard | −16.28 | (−18.44, −14.06) | <.0001 |
| Insulin (mU/L) | Standard | −18.87 | (−22.27, −15.33) | <.0001 |
| Standard + FMI | −7.69 | (−11.37, −3.85) | <.001 | |
| HOMA‐insulin resistance | Standard | −18.80 | (−22.22, −15.23) | <.0001 |
| Standard + FMI | −7.68 | (−11.40, −3.80) | <.001 | |
| HbA1c (%) | Standard | −0.56 | (−1.02, −0.10) | .02 |
| Standard + FMI | −0.34 | (−0.83, 0.15) | .17 | |
| Glucose (mmol/L) | Standard | −0.99 | (−1.53, −0.45) | <.001 |
| Standard + FMI | −0.67 | (−1.24, −0.09) | .02 | |
| Urate (mmol/L) | Standard | −5.85 | (−7.56, −4.10) | <.0001 |
| Standard + FMI | −2.19 | (−3.99, −0.35) | .02 | |
| C‐reactive protein (mg/L) | Standard | −40.85 | (−46.11, −35.06) | <.0001 |
| Standard + FMI | −20.84 | (−27.52, −13.54) | <.0001 | |
| Triglyceride (mmol/L) | Standard | −9.79 | (−12.27, −7.24) | <.0001 |
| Standard + FMI | −5.26 | (−7.93, −2.51) | <.001 | |
| HDL‐cholesterol (mmol/L) | Standard | 3.78 | (2.18, 5.41) | <.0001 |
| Standard + FMI | 0.78 | (−0.81, 2.39) | .34 | |
| LDL‐cholesterol (mmol/L) | Standard | −3.47 | (−5.34, −1.57) | <.001 |
| Standard + FMI | −1.80 | (−3.80, 0.24) | .08 | |
| Systolic blood pressure (mm Hg) | Standard | −2.46 | (−3.22, −1.70) | <.0001 |
| Standard + FMI | −1.69 | (−2.48, −0.89) | <.0001 | |
| Diastolic blood pressure (mm Hg) | Standard | −3.17 | (−3.86, −2.49) | <.0001 |
| Standard + FMI | −2.66 | (−3.38, −1.94) | <.0001 | |
Percentage differences are shown for all variables which are log‐transformed.
Standard adjustment is for sex, age (in quartiles), ethnic group, month of measurement, height, and school (random effect).
Absolute differences are shown for untransformed variables.
Ethnic differences in risk markers for type 2 diabetes and cardiovascular disease: effect of adjustment for estimated VO2 max
| Percentage difference/difference | |||||
|---|---|---|---|---|---|
| Risk markers ( | Adjustments | South Asian‐white European | |||
| Insulin (mU/L) | Standard | 38.63 | (26.78, 51.59) | <.0001 | |
| Standard + VO2 max | 34.52 | (23.32, 46.73) | <.0001 | 10.6 | |
| HOMA‐insulin resistance | Standard | 39.34 | (27.41, 52.39) | <.0001 | |
| Standard + VO2 max | 35.19 | (23.90, 47.50) | <.0001 | 10.5 | |
| HbA1c (%) | Standard | 1.93 | (1.00, 2.86) | <.0001 | |
| Standard + VO2 max | 1.85 | (0.92, 2.78) | <.0001 | 4.1 | |
| Glucose (mmol/L) | Standard | 1.41 | (0.31, 2.51) | .01 | |
| Standard + VO2 max | 1.25 | (0.16, 2.36) | .02 | 11.3 | |
| Urate (mmol/L) | Standard | 1.76 | (−1.91, 5.57) | .35 | |
| Standard + VO2 max | 0.86 | (−2.72, 4.58) | .64 | 51.1 | |
| C‐reactive protein (mg/L) | Standard | 20.80 | (0.21, 45.63) | .05 | |
| Standard + VO2 max | 10.37 | (−8.09, 32.54) | .29 | 50.1 | |
| Triglyceride (mmol/L) | Standard | 15.63 | (9.27, 22.36) | <.0001 | |
| Standard + VO2 max | 13.92 | (7.74, 20.44) | <.0001 | 10.9 | |
| HDL‐cholesterol (mmol/L) | Standard | −4.27 | (−7.20, −1.24) | .01 | |
| Standard + VO2 max | −3.72 | (−6.66, −0.68) | .02 | 12.9 | |
| LDL‐cholesterol (mmol/L) | Standard | 1.87 | (−1.92, 5.80) | .34 | |
| Standard + VO2 max | 1.31 | (−2.45, 5.21) | .50 | 29.9 | |
| Systolic blood pressure (mm Hg) | Standard | −0.47 | (−2.02, 1.09) | .56 | |
| Standard + VO2 max | −0.83 | (−2.37, 0.71) | .29 | −76.6 | |
| Diastolic blood pressure (mm Hg) | Standard | 1.19 | (−0.21, 2.59) | .10 | |
| Standard + VO2 max | 0.76 | (−0.61, 2.13) | .28 | 36.1 | |
Percentage differences are shown for all variables which are log‐transformed.
Standard adjustment is for sex, age (in quartiles), ethnic group, month of measurement, height, and school (random effect).
Absolute differences are shown for untransformed variables.